Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Stock Up 8.21 Percent on News of Microchip Permeation-Layer Patent

NEW YORK, Jan. 6 (GenomeWeb News) - Nanogen shares were up 8.21 percent at $6.72 in late-afternoon trading after the company said it won a patent for its chip technology.


The pastent, No. 6,838,053, covers  methods of producing a covalently bonded permeation layer on a microchip, to be used in the analysis of biological molecules.


It relates to "chemistries used to create the permeation layer, which allows electrochemical products generated at the electrode surface to travel through the layer and into the solution immediately above the electrodes," according to a Nanogen statement.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.